Comparative Evaluation of Pioglitazone versus Voglibose on Lipid Profile in Patients with Type 2 Diabetes Mellitus Add On Metformin

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2018, Vol 6, Issue 9

Abstract

Type 2 Diabetes mellitus (Type 2 DM) is a heterogeneous group of disorders associated with both macrovascular and microvascular complications. Due to progressive nature of type 2 DM, dual drug therapy produces additive effects, allows the use of submaximal doses, and less side effects of individual agents. Therefore, the present study was designed to study the effect of pioglitazone in comparison to voglibose on Lipid profile control as an add-on drug in patients with Type 2 DM whose glycemic status was uncontrolled with metformin alone. The present study was open, randomized parallel group comparison of two active treatment groups over a period of six months. Sixty-seven patients of either sex in the age group of 30-60 years, suffering from type 2 DM, with FBG ≥ 126 mg/dl and PPBG ≥ 200 mg/dl as per ADA were selected at randomly. The effect of pioglitazone and voglibose were observed on various parameters of Lipid Profile (Total cholesterol, TG, HDL, LDL, VLDL). At the end of 6 months it was observed that though both pioglitazone and voglibose reduced Lipid levels significantly but pioglitazone caused a significantly greater percentage change in Lipid levels as compared with voglibose. Few side effects were observed with voglibose and not with pioglitazone. Though pioglitazone and voglibose were equally effective in lowering Lipid levels yet pioglitazone showed better results in improving dyslipidemia, as compared to voglibose. Pioglitazone had minimal side effects as compared to voglibose.

Authors and Affiliations

MD Faheem Mubeen, Dr. Deepak Bhosle

Keywords

Related Articles

Adverse drug reaction reporting among clinicians in a teaching hospital in South Karnataka

The study was aimed at investigating knowledge, attitude and practice of clinicians towards ADR reporting, to identify the reasons for underreporting and suggestions to improve the ADR reporting system. A questionnaire s...

To Compare the Effects of Dexmedetomidine and Midazolam for Conscious Sedation in Patients Undergoing Upper Gastrointestinal Endoscopic Procedures- an open labelled prospective study

Abstract: Our aim was to compare the hemodynamic parameters, sedation profile, duration of procedure and recovery profile of intravenous Dexmedetomidine and Midazolam in patients undergoing upper gastrointestinal endosco...

The Correlation between Placental Thickness and Fetal Age among the Pregnants in Sudan

The placenta is a fetal organ which provides the physiological link between pregnant woman and her fetus. The placenta is highly vascularized organ and its main functions are exchange of metabolic and gaseous products be...

A Study of Outcome of Preterm Babies in a Low Resource Hospital

Preterm birth is one of the major problems with increased perinatal mortality and morbidity. The aim was to evaluate the outcome of preterm babies in a low resource hospital. A retrospective study was conducted over a pe...

Primary Mucinous Cystadenocarcinoma of Breast: A Rare Case Report

The primary mucinous cystadenocarcinoma of the breast is an extremely rare and primary malignancy of breast. It was first described by Koenig and Tavassoli in 1998. It is defined as carcinoma composed of generally tall c...

Download PDF file
  • EP ID EP479697
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

MD Faheem Mubeen, Dr. Deepak Bhosle (2018). Comparative Evaluation of Pioglitazone versus Voglibose on Lipid Profile in Patients with Type 2 Diabetes Mellitus Add On Metformin. Scholars Journal of Applied Medical Sciences, 6(9), 3461-3471. https://europub.co.uk/articles/-A-479697